![Karen L. Roberts](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Karen L. Roberts
Corporate Officer/Principal chez
Massachusetts Biotechnology Council
Profil
Ms. Karen L.
Roberts is Senior Vice President-Finance & Administration at Cerulean Pharma, Inc., a Member at Massachusetts Biotechnology Council, and a Principal at The Financial Executives Institute.
Ms. Roberts was previously employed as Vice President-Finance & Administration by Elixir Pharmaceuticals, Inc., a Principal by Dyax Corp., a Principal by The Frontline Group, and a Principal by T Cell Sciences, Inc.
She received her undergraduate degree from Salem State College.
Postes actifs de Karen L. Roberts
| Sociétés | Poste | Début |
|---|---|---|
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Corporate Officer/Principal | 27/08/2009 |
The Financial Executives Institute | Corporate Officer/Principal | 27/08/2009 |
Anciens postes connus de Karen L. Roberts
| Sociétés | Poste | Fin |
|---|---|---|
Cerulean Pharma, Inc.
 Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Directeur Financier/CFO | 28/05/2015 |
T Cell Sciences, Inc.
 T Cell Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for diseases of the immune system | Corporate Officer/Principal | - |
The Frontline Group
 The Frontline Group Miscellaneous Commercial ServicesCommercial Services Provides consulting and training services | Corporate Officer/Principal | - |
| DYAX CORP. | Corporate Officer/Principal | - |
Elixir Pharmaceuticals, Inc.
 Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Directeur Administratif | - |
Formation de Karen L. Roberts
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
77
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
T Cell Sciences, Inc.
T Cell Sciences, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for diseases of the immune system | Health Technology |
The Frontline Group
The Frontline Group Miscellaneous Commercial ServicesCommercial Services Provides consulting and training services | Commercial Services |
Elixir Pharmaceuticals, Inc.
Elixir Pharmaceuticals, Inc. Investment Trusts/Mutual FundsMiscellaneous Operates as a holding company with interest in manufacturing and developing biopharmaceutical products for the treatment of metabolic diseases | Miscellaneous |
Salem State University
 Salem State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Financial Executives Institute | |
Cerulean Pharma, Inc.
Cerulean Pharma, Inc. Pharmaceuticals: MajorHealth Technology Design and develops nanopharmaceuticals | Health Technology |
Massachusetts Biotechnology Council
Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Operates as an association of biotechnology companies | Commercial Services |
